CareDx (CDNA): Director granted 1,753 shares; holdings 155,969
CareDx, Inc. (CDNA) reported an automatic non-employee director equity grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CareDx, Inc. (CDNA) reported an automatic non-employee director equity grant. On 10/06/2025 the reporting person received 1,753 shares of common stock as an automatic quarterly grant in lieu of cash under the companys Outside Director Compensation Policy. The reported price for the grant is $0, and the reporting persons total beneficial ownership after the grant is 155,969 shares. The Form 4 was signed by an attorney-in-fact on 10/07/2025.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,753 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents an automatic quarterly grant of common stock to the Reporting Person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What change did the CareDx (CDNA) Form 4 report?
Why was the grant issued to the reporting person?
When was the Form 4 signed and filed?
AI-generated analysis. How Rhea-AI works. Not financial advice.